<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39439800</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome.</ArticleTitle><Pagination><StartPage>1439789</StartPage><MedlinePgn>1439789</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1439789</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1439789</ELocationID><Abstract><AbstractText>Granulocyte-macrophage colony stimulating factor (GM-CSF) is a pleiotropic cytokine, able to promote both myelopoiesis and activation of immune cells. Particularly in the lung, GM-CSF plays an important homeostatic role in the development and maintenance of alveolar macrophages, and is therefore considered to play a role in respiratory virus infections such as influenza and SARS-CoV-2, although the benefits of GM-CSF treatment in clinical studies remain inconclusive. To address this, we tested inhaled GM-CSF treatment in the Pneumonia Virus of Mice (PVM) mouse model. Our findings show that local GM-CSF therapy during PVM disease increased local neutrophilia and monocyte-derived cell influx, but diminished CD8<sup>+</sup> T cells responses. Despite this, the observed effects on T cells and myeloid cells did not result in an altered clinical outcome during PVM infection. We conclude that inhaled GM-CSF therapy cannot be considered as a universal protective therapy in respiratory virus infections.</AbstractText><CopyrightInformation>Copyright © 2024 Debeuf, Deckers, Lameire, Bosteels, Hammad and Lambrecht.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Debeuf</LastName><ForeName>Nincy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deckers</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lameire</LastName><ForeName>Sahine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosteels</LastName><ForeName>Cedric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammad</LastName><ForeName>Hamida</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambrecht</LastName><ForeName>Bart N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>83869-56-1</RegistryNumber><NameOfSubstance UI="D016178">Granulocyte-Macrophage Colony-Stimulating Factor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016178" MajorTopicYN="Y">Granulocyte-Macrophage Colony-Stimulating Factor</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018186" MajorTopicYN="Y">Pneumovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022423" MajorTopicYN="N">Myeloid Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD8 T cells</Keyword><Keyword MajorTopicYN="N">GM-CSF</Keyword><Keyword MajorTopicYN="N">inhalation therapy</Keyword><Keyword MajorTopicYN="N">pneumonia virus of mice</Keyword><Keyword MajorTopicYN="N">viral infection</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>10</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39439800</ArticleId><ArticleId IdType="pmc">PMC11493702</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1439789</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Borriello F, Galdiero MR, Varricchi G, Loffredo S, Spadaro G, Marone G. Innate immune modulation by GM-CSF and IL-3 in health and disease. Int J Mol Sci. (2019) 20:834. doi: 10.3390/ijms20040834</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20040834</ArticleId><ArticleId IdType="pmc">PMC6412223</ArticleId><ArticleId IdType="pubmed">30769926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton JA. GM-CSF in inflammation. J Exp Med. (2020) 217:3453. doi: 10.1084/jem.20190945</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190945</ArticleId><ArticleId IdType="pmc">PMC7037240</ArticleId><ArticleId IdType="pubmed">31611249</ArticleId></ArticleIdList></Reference><Reference><Citation>Aegerter H, Lambrecht BN, Jakubzick CV. Biology of lung macrophages in health and disease. Immunity. (2022) 55:1564–80. doi: 10.1016/j.immuni.2022.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.08.010</ArticleId><ArticleId IdType="pmc">PMC9533769</ArticleId><ArticleId IdType="pubmed">36103853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Ikegami M, Reed JA, Chroneos ZC, Whitsett JA. GM-CSF regulates protein and lipid catabolism by alveolar macrophages. Am J Physiol-Lung Cell Mol Physiol. (2001) 280:L379–86. doi: 10.1152/ajplung.2001.280.3.l379</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.2001.280.3.l379</ArticleId><ArticleId IdType="pubmed">11159019</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M, Kleer ID, Henri S, Post S, Vanhoutte L, Prijck SD, et al. . Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med. (2013) 210:1977–92. doi: 10.1084/jem.20131199</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20131199</ArticleId><ArticleId IdType="pmc">PMC3782041</ArticleId><ArticleId IdType="pubmed">24043763</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman JA, Hull WM, Dranoff G, Mulligan RC, Whitsett JA. Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Investig. (1996) 97:649–55. doi: 10.1172/jci118461</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci118461</ArticleId><ArticleId IdType="pmc">PMC507100</ArticleId><ArticleId IdType="pubmed">8609219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosteels C, Damme KFAV, Leeuw ED, Declercq J, Maes B, Bosteels V, et al. . Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment. Cell Rep Med. (2022) 3:100833. doi: 10.1016/j.xcrm.2022.100833</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100833</ArticleId><ArticleId IdType="pmc">PMC9663750</ArticleId><ArticleId IdType="pubmed">36459994</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman TK, Singh AK, Bonin JL, Nafiz TN, Salmon SL, Metzger DW. Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination. JCI Insight. (2022) 7. doi: 10.1172/jci.insight.159422</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.159422</ArticleId><ArticleId IdType="pmc">PMC9220949</ArticleId><ArticleId IdType="pubmed">35482422</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang FM, Lee KM-C, Teijaro JR, Becher B, Hamilton JA. GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches. Nat Rev Immunol. (2020) 20:507–14. doi: 10.1038/s41577-020-0357-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0357-7</ArticleId><ArticleId IdType="pmc">PMC7309428</ArticleId><ArticleId IdType="pubmed">32576980</ArticleId></ArticleIdList></Reference><Reference><Citation>Paine R, Chasse R, Halstead ES, Nfonoyim J, Park DJ, Byun T, et al. . Inhaled sargramostim (Recombinant human granulocyte-macrophage colony-stimulating factor) for COVID-19-associated acute hypoxemia: results of the phase 2, randomized, open-label trial (iLeukPulm). Mil Med. (2022) 188:e2629–38. doi: 10.1093/milmed/usac362</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/usac362</ArticleId><ArticleId IdType="pmc">PMC10363010</ArticleId><ArticleId IdType="pubmed">36458916</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F-F, Barnes PF, Feng Y, Donis R, Chroneos ZC, Idell S, et al. . GM-CSF in the lung protects against lethal influenza infection. Am J Resp Crit Care. (2012) 184:259–68. doi: 10.1164/rccm.201012-2036oc</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201012-2036oc</ArticleId><ArticleId IdType="pmc">PMC6938174</ArticleId><ArticleId IdType="pubmed">21474645</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam R, Hillberry Z, Chen H, Feng Y, Fletcher K, Neuenschwander P, et al. . Delivery of GM-CSF to protect against influenza pneumonia. PloS One. (2015) 10:e0124593. doi: 10.1371/journal.pone.0124593</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124593</ArticleId><ArticleId IdType="pmc">PMC4414562</ArticleId><ArticleId IdType="pubmed">25923215</ArticleId></ArticleIdList></Reference><Reference><Citation>Unkel B, Hoegner K, Clausen BE, Lewe-Schlosser P, Bodner J, Gattenloehner S, et al. . Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest. (2012) 122:3652–64. doi: 10.1172/jci62139</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci62139</ArticleId><ArticleId IdType="pmc">PMC3461909</ArticleId><ArticleId IdType="pubmed">22996662</ArticleId></ArticleIdList></Reference><Reference><Citation>Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, et al. . GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity. (2012) 36:1031–46. doi: 10.1016/j.immuni.2012.03.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.03.027</ArticleId><ArticleId IdType="pmc">PMC3498051</ArticleId><ArticleId IdType="pubmed">22749353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosteels C, Neyt K, Vanheerswynghels M, van Helden MJ, Sichien D, Debeuf N, et al. . Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection. Immunity. (2020) 52:1039–1056.e9. doi: 10.1016/j.immuni.2020.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.005</ArticleId><ArticleId IdType="pmc">PMC7207120</ArticleId><ArticleId IdType="pubmed">32392463</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanheerswynghels M, Toussaint W, Schuijs M, Vanhoutte L, Killeen N, Hammad H, et al. . The generation and use of allergen-specific TCR transgenic animals. Methods Mol Biol (Clifton NJ). (2018) 1799:183–210. doi: 10.1007/978-1-4939-7896-0_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7896-0_15</ArticleId><ArticleId IdType="pubmed">29956153</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinder EM, Rostron AJ, Hellyer TP, Ruchaud-Sparagano M-H, Scott J, Macfarlane JG, et al. . Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. Thorax. (2018) 73:918. doi: 10.1136/thoraxjnl-2017-211323</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2017-211323</ArticleId><ArticleId IdType="pmc">PMC6166597</ArticleId><ArticleId IdType="pubmed">30064991</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Mara AB, Musial SC, Kolling FW, Gibbings SL, Gerebtsov N, et al. . Coordinated chemokine expression defines macrophage subsets across tissues. Nat Immunol. (2024) 25, 1–13. doi: 10.1038/s41590-024-01826-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-024-01826-9</ArticleId><ArticleId IdType="pubmed">38698086</ArticleId></ArticleIdList></Reference><Reference><Citation>Achuthan A, Cook AD, Lee M-C, Saleh R, Khiew H-W, Chang MWN, et al. . Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation. J Clin Investig. (2016) 126:3453–66. doi: 10.1172/jci87828</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci87828</ArticleId><ArticleId IdType="pmc">PMC5004969</ArticleId><ArticleId IdType="pubmed">27525438</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawat K, Tewari A, Li X, Mara AB, King WT, Gibbings SL, et al. . CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes. J Exp Med. (2023) 220:e20222129. doi: 10.1084/jem.20222129</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20222129</ArticleId><ArticleId IdType="pmc">PMC10072223</ArticleId><ArticleId IdType="pubmed">36946983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortjens B, Lutter R, Boon L, Bem RA, van Woensel JBM. Pneumovirus-induced lung disease in mice is independent of neutrophil-driven inflammation. PloS One. (2016) 11:e0168779. doi: 10.1371/journal.pone.0168779</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168779</ArticleId><ArticleId IdType="pmc">PMC5179008</ArticleId><ArticleId IdType="pubmed">28005954</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey S, Krempl CD, Schmitt-Gräff A, Ehl S. Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol. (2008) 82:11619–27. doi: 10.1128/jvi.00375-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00375-08</ArticleId><ArticleId IdType="pmc">PMC2583671</ArticleId><ArticleId IdType="pubmed">18815308</ArticleId></ArticleIdList></Reference><Reference><Citation>van Helden MJG, van Kooten PJS, Bekker CPJ, Gröne A, Topham DJ, Easton AJ, et al. . Pre-existing virus-specific CD8+ T-cells provide protection against pneumovirus-induced disease in mice. Vaccine. (2012) 30:6382–8. doi: 10.1016/j.vaccine.2012.08.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.08.027</ArticleId><ArticleId IdType="pmc">PMC3465553</ArticleId><ArticleId IdType="pubmed">22940382</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh KB, Teijaro JR, Brock LG, Fremgen DM, Collins PL, Rosen H, et al. . Animal model of respiratory syncytial virus: CD8 + T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. J Virol. (2014) 88:6281–93. doi: 10.1128/jvi.00464-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00464-14</ArticleId><ArticleId IdType="pmc">PMC4093868</ArticleId><ArticleId IdType="pubmed">24672024</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Carrington EM, van Nieuwenhuijze A, Bedoui S, Seah S, Xu Y, et al. . GM-CSF increases cross-presentation and CD103 expression by mouse CD8+ spleen dendritic cells. Eur J Immunol. (2011) 41:2585–95. doi: 10.1002/eji.201141540</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201141540</ArticleId><ArticleId IdType="pubmed">21660938</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold IC, Artola-Boran M, Gurtner A, Bertram K, Bauer M, Frangez Z, et al. . The GM-CSF-IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses. J Exp Med. (2020) 217:2055. doi: 10.1084/jem.20190706</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190706</ArticleId><ArticleId IdType="pmc">PMC7953737</ArticleId><ArticleId IdType="pubmed">32970801</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider A, Weier M, Herderschee J, Perreau M, Calandra T, Roger T, et al. . IRF5 is a key regulator of macrophage response to lipopolysaccharide in newborns. Front Immunol. (2018) 9:1597. doi: 10.3389/fimmu.2018.01597</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01597</ArticleId><ArticleId IdType="pmc">PMC6050365</ArticleId><ArticleId IdType="pubmed">30050534</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA. IRF5 is a specific marker of inflammatory macrophages in vivo . Mediat Inflammation. (2013) 2013:245804. doi: 10.1155/2013/245804</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/245804</ArticleId><ArticleId IdType="pmc">PMC3885211</ArticleId><ArticleId IdType="pubmed">24453413</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbin AL, Gomez-Vazquez M, Berthold DL, Attar M, Arnold IC, Powrie FM, et al. . IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation. Sci Immunol. (2020) 5. doi: 10.1126/sciimmunol.aax6085</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aax6085</ArticleId><ArticleId IdType="pmc">PMC7611075</ArticleId><ArticleId IdType="pubmed">32444476</ArticleId></ArticleIdList></Reference><Reference><Citation>Casacuberta-Serra S, Parés M, Golbano A, Coves E, Espejo C, Barquinero J. Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes. Immunol Cell Biol. (2017) 95:538–48. doi: 10.1038/icb.2017.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2017.4</ArticleId><ArticleId IdType="pubmed">28108746</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce D, Fujino M, Morita M, Araki R, Fung J, Qian S, et al. . Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response. Stem Cell Res. (2018) 29:32–41. doi: 10.1016/j.scr.2018.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.03.009</ArticleId><ArticleId IdType="pubmed">29574174</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M-Y, Lim B-G, Kim S-Y, Sohn H-J, Kim S, Kim T-G. GM-CSF promotes the expansion and differentiation of cord blood myeloid-derived suppressor cells, which attenuate xenogeneic graft-vs.-host disease. Front Immunol. (2019) 10:183. doi: 10.3389/fimmu.2019.00183</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00183</ArticleId><ArticleId IdType="pmc">PMC6399310</ArticleId><ArticleId IdType="pubmed">30863394</ArticleId></ArticleIdList></Reference><Reference><Citation>Calì B, Agnellini AHR, Cioccarelli C, Sanchez-Rodriguez R, Predonzani A, Toffolo GI, et al. . GM-CSF nitration is a new driver of myeloid suppressor cell activity in tumors. Front Immunol. (2021) 12:718098. doi: 10.3389/fimmu.2021.718098</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.718098</ArticleId><ArticleId IdType="pmc">PMC8523982</ArticleId><ArticleId IdType="pubmed">34675917</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolcetti L, Peranzoni E, Ugel S, Marigo I, Gomez AF, Mesa C, et al. . Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol. (2010) 40:22–35. doi: 10.1002/eji.200939903</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200939903</ArticleId><ArticleId IdType="pubmed">19941314</ArticleId></ArticleIdList></Reference><Reference><Citation>King RJ, Shukla SK, He C, Vernucci E, Thakur R, Attri KS, et al. . CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Oncogene. (2022) 41:971–82. doi: 10.1038/s41388-021-02132-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-021-02132-6</ArticleId><ArticleId IdType="pmc">PMC8840971</ArticleId><ArticleId IdType="pubmed">35001076</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinchi Y, Ishizuka S, Komohara Y, Matsubara E, Mito R, Pan C, et al. . The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma. Cancer Immunol Immunother. (2022) 71:2645–61. doi: 10.1007/s00262-022-03187-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-022-03187-4</ArticleId><ArticleId IdType="pmc">PMC8963674</ArticleId><ArticleId IdType="pubmed">35352168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonemitsu K, Pan C, Fujiwara Y, Miyasato Y, Shiota T, Yano H, et al. . GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer. Sci Rep. (2022) 12:12007. doi: 10.1038/s41598-022-16080-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-16080-y</ArticleId><ArticleId IdType="pmc">PMC9283541</ArticleId><ArticleId IdType="pubmed">35835809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tewari A, Prabagar MG, Gibbings SL, Rawat K, Jakubzick CV. LN monocytes limit DC-poly I:C induced cytotoxic T cell response via IL-10 and induction of suppressor CD4 T cells. Front Immunol. (2021) 12:763379. doi: 10.3389/fimmu.2021.763379</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.763379</ArticleId><ArticleId IdType="pmc">PMC8527167</ArticleId><ArticleId IdType="pubmed">34691085</ArticleId></ArticleIdList></Reference><Reference><Citation>Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, et al. . Unique chemotactic response profile and specific expression of chemokine receptors ccr4 and ccr8 by cd4+Cd25+ Regulatory T cells. J Exp Med. (2001) 194:847–54. doi: 10.1084/jem.194.6.847</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.194.6.847</ArticleId><ArticleId IdType="pmc">PMC2195967</ArticleId><ArticleId IdType="pubmed">11560999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>